SCR-LIP-000493 · Claim · machine-readable JSON →
This scoping review of lipedema treatments (2020-2025) identified zero eligible studies on pharmacological treatment, with gestrinone not mentioned among any evaluated or proposed drug therapies (selenium, butcher's broom, diosmin, metformin, exenatide).
This single-paper claim was consolidated into general propositions (R-CLM-19); its evidence now sits under:
Claim at a glance
- Type
- clinical association
- Knowledge state
- Emerging
- Evidence certainty
- very low (GRADE)
- Evidence
- 1 source(s)
- Answers
- 0 question(s)
- Dates
- 2026-11-17 → 2026-11-17
Structured evidence, machine-compiled — not a verdict.
Auto-compiled by the Layer 1 surveillance loop; not yet human-reviewed. anthropic/claude-opus-4.8 · 2026-11-17
Evidence over time
Evidence (1)
- Treatment Strategies for Lipedema: A Scoping Review on liposuction, compression therapy, bariatric surgery and pharmacological treatment (2026) ✓ verified — conflicting · review · 2026 · reading confidence: high
“TRATAMENTO FARMACOLÓGICO (0 estudos elegíveis): NENHUMA evidência primária dentro do escopo da busca.”
The review found no eligible pharmacological studies and does not mention gestrinone at all; proposed drugs were deemed insufficient, providing no affirmative evidence for gestrinone efficacy.
Context (PECO)
Answers these questions
- Not yet linked to a question.
Gaps & caveats
Auto-ingested single source; not yet human-reviewed.
Change log
- 2026-11-17 — created · auto-ingested for SQ-LIP-000016
- 2026-11-20 — consolidated · SQ-LIP-000016: evidence moved to SCR-LIP-000670